Xconomy San Diego

Advancing a Stem Cell Treatment for Diabetes

11/17/09
12 pm – 1:30 pm
AMN Healthcare, 12400 High Bluff Drive, 92130

Recent breakthroughs have enabled E. Edward Baetge’s team at San Diego-based Novocell to develop and patent an innovative stem cell therapy that yields functional pancreatic, insulin-producing cells using human embryonic stem cells. Baetge outlines development of a potential therapy that injects such stem cells into the bodies of diabetics to replace cells that no longer produce insulin. More information and online registration is available here.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.